Thursday, February 28, 2019

American States Water (AWR) Q4 2018 Earnings Conference Call Transcript

Logo of jester cap with thought bubble with words 'Fool Transcripts' below it

Image source: The Motley Fool.

American States Water (NYSE:AWR) Q4 2018 Earnings Conference CallFeb. 26, 2019 2:00 p.m. ET

Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the American States Water Company conference call discussing the company's fourth-quarter and full-year 2018 results. The call is being recorded. If you would like to listen to the replay of this call, it will begin this afternoon at approximately 5:00 p.m.

Eastern time and run through Tuesday, March 5, 2019 on the company's website, www.aswater.com. The slides that the company will be referring to are also available on the website. [Operator instructions] This call will be limited to 1 hour. Presenting today from American States Water Company is Bob Sprowls, president and chief executive officer; and Eva Tang, senior vice president of finance and chief financial officer.

As a reminder, certain matters discussed during this conference call may be forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Please review a description of the company's risks and uncertainties in our most recent Form 10-K and Form 10-Q on file with the Securities and Exchange Commission. In addition, this conference call will include a discussion of certain measures that are not prepared in accordance with generally accepted accounting principles, or GAAP, in the United States and constitute non-GAAP financial measures under SEC rules. These non-GAAP financial measures are derived from consolidated financial information but are not presented in our financial statements that are prepared in accordance with GAAP.

For more details, please refer to the press release. At this time, I would like to turn the call over to Bob Sprowls, president and chief executive officer of American States Water Company. Please go ahead.

Bob Sprowls -- President and Chief Executive Officer

Thank you, Nicole. Welcome everyone, and thank you for joining us today. I'll begin with some highlights for the year; Eva will then discuss some financial details; and then I'll wrap it up with some updates on regulatory filings, ASUS and dividends, and then we'll take your questions. For American States Water and its two subsidiaries, 2018 represented a continued unwavering commitment to safe and reliable service for our water, wastewater and electric customers, both in California, as well as in eight other states where we serve the country's military personnel and their families.

We concluded 2018 with two settled rate cases for our water and electric utilities, a record level of capital investments in our regulated utility, earned a record high earnings per share contribution at our contracted services subsidiary, commenced operations of water and our wastewater systems at our 11th military base and continued our 64-consecutive-year history of dividend increases. At Golden State Water Company, we reached settlements with the California Public Utilities Commission's Public Advocates Office on all issues for our pending water and electric rate cases. The water rate case sets new rates for the years 2019 through 2021 while the electric rate case, under the settlement, will set new rates for 2018 through 2022. We continue to invest in the reliability of our systems, spending a historical high of $121 million in needed infrastructure during the year.

At American States Utility Services, or ASUS, we achieved the highest annual earnings per share contribution. In 2018, we further grew our military base footprint by commencing operations at our newest base, Fort Riley, increased our services at existing bases and continue to work with the U.S. government on price adjustments and asset transfers. ASUS now provides services for water and our wastewater systems and treatment plants to 11 military bases, including some of the largest military installations in the United States: Fort Bragg, Fort Bliss, Eglin Air Force Base and Fort Riley, as well as one of the most high-profile bases, Joint Base Andrews.

During 2018, ASUS was awarded $24 million in new construction projects, the majority of which are expected to be completed in 2019. AWR stock achieved a total shareholder return of 17.9% for 2018, which was substantially higher than the S&P 500 performance, which had a loss of 4.4% for 2018. American States Water also achieved a consolidated return on equity of 11.7%. In addition, we increased our quarterly dividend by 7.8%, continuing our record of 64 consecutive years of annual dividend increases.

We remain committed to our communities. Golden State Water continued to increase its spending with diverse business enterprises, with 2018 results well above the California Public Utilities Commission's requirement. In addition, ASUS continue to exceed the U.S. government's requirements to hire small business contractors to perform work on the bases it serves.

And we are proud to say that in 2018, our employees donated over 6,000 hours of community outreach and engagement in areas they live and work. For 2018, we earned $1.72 per fully diluted share. As you can see from this slide, if we excluded the onetime gain of $0.13 per share for the sale of the Ojai water system, a $0.02 per share recovery for previously incurred drought costs, gains and losses received or incurred on investments held to fund a retirement benefit plan, as well as retroactive revenues at ASUS of $0.02 per share recorded in 2017, earnings-per-share for 2018 was a $0.06 per share increase compared to 2017. These results were accomplished despite a lower rate of return based on the water utilities cost of capital decision, as well as a delayed electric general rate case decision.

Had the new rates in the electric joint settlement agreement been approved by the CPUC in 2018, the Electric segment would have contributed an additional $0.04 per share. Eva will discuss the 2018 performance in more detail later. As we look ahead, the company's strategy remains the same: deliver outstanding customer service, make prudent capital additions and continue to grow our military base presence around the country. I will now turn the call over to Eva to review the financial results for the quarter.

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

Thank you, Bob, and hello, everyone. Let me start with an overview of our fourth-quarter financial results on Slide 9. Consolidated earnings for the quarter were $0.37 per share, compared to $0.35 per share for the same period in 2017. As Bob mentioned, results were affected by losses of $1.4 million or $0.03 per share incurred during the fourth quarter of 2018 on investments held to fund a retirement benefit plan due to market conditions, as compared to investment gains of $600,000 or $0.01 per share recorded in the fourth quarter of 2017.

This resulted in a $0.04 per share earnings decrease on a comparative basis. Excluding this noncore business item, consolidated earnings for the quarter increased by $0.06 per share compared to the fourth quarter of 2017. Consolidated revenues increased by $6.8 million due to the commencement of operations at Fort Riley, continued revenue increases at Eglin Air Force Base since we took over its operations in June of 2017, as well as higher construction activity at Fort Bragg. Water revenues decreased slightly in 2018 due to downward adjustment to revenues resulting from the tax reform, a lower authorized rate of return based on the CPUC's decision on the March 2018 water cost of capital application and decreases related to the expiration of various surcharges that were in place to recover previously incurred costs.

These decreases were largely offset by CPUC-approved 30-year rate increases for 2018. Electric revenues were higher due to a downward adjustment to revenue requirement recorded in the fourth quarter of 2017 to reflect a decrease in the general office allocation. As Bob mentioned, we reached a joint settlement in our electric GRC for new rates retroactive to January 2018. If approved, the Electric segment's gross margin would have been higher than recorded by approximately $575,000 or $0.01 per share for the three months ended December 31, 2018 and approximately $2 million or $0.04 per share for the entire 2018 year.

Looking at Slide 11. Our water and electric supply cost were $21.6 million for the quarter, an increase of $1 million from last year. Any changes in supply cost for both the water and electric segment as compared to the adopted supply costs are tracked in balancing accounts. Looking at total operating expenses, excluding supply cost and surcharges, consolidated expenses increased $5.7 million versus the fourth quarter of 2017 due to an increase in construction costs at ASUS as the result of higher construction activity, a reduction in legal costs of $1.8 million recorded in 2017 in connection with the settlement agreement and higher depreciation and amortization expenses in 2018 due to planned additions.

Including gains and losses from -- excluding gains and losses from investments, interest and other income net of interest expense increased by $909,000 or nearly $0.02 per share due primarily to interest income related to a federal tax refund recorded during the fourth quarter of 2018. Slide 12 shows the EPS bridge comparing the fourth quarter of 2018 with the same quarter of 2017. Turning to Slide 13 for the full-year results, included in 2017's Water segment results were the recognition of a pre-tax gain of $8.3 million or $0.13 per share on the sale of our Ojai water system in 2017; the recovery in 2017 of previously incurred drought-related costs, which resulted in a $1.5 million increase in pre-tax earnings or $0.02 per share for 2017; and about $1.7 million or $0.04 per share of gains on company's investment in 2017 as compared to $560,000 losses in 2018 due to market conditions. Excluding the impact of these items, earnings from the Water segment for 2018 increased by $0.04 per share as compared to 2017.

The $0.04 increase was due to a higher water gross margin from the 30-year rate increases, partially offset by the effect of the cessation of the Ojai operations in 2017 and the impact from the lower authorized return in the 2018 cost of capital proceedings. There were also an increase in interest and other income due to interest income related to a federal tax refund recorded in the fourth quarter of 2018. Lastly, a lower effective income tax rate positively affected earnings for 2018. It was due, in large part, to the unfavorable remeasurement adjustment of deferred tax balances in connection with the tax reform, which negatively impacted the Water segment's earning in 2017 by approximately $0.03 per share.

These increases were partially offset by an increase in operating expenses due to higher legal, depreciation and property tax expenses. Moving on to the electric segment, earnings were flat in 2018 at $0.11 per share due to the delay in the electric GRC. Billed revenue in 2018 were based on 2017 adopted rates, pending a CPUC decision. Again, if the settlement was approved in 2018, the segment's gross margin would have been higher in 2018 by $2 million or $0.04 per share.

Included in ASUS's results for 2017 were retroactive revenue of $1 million or $0.02 per share, resulting from the approval of the third price redetermination at Fort Bragg related to periods prior to 2017. Excluding this retroactive amount, diluted earnings per share from the contracted services segment increased $0.07 per share as compared to 2017, largely due to operations at Eglin Air Force Base and Fort Riley. There was also an increase in management fee revenues at the other military bases, resulting from successful resolutions of various price adjustments. AWR parents earnings decreased $0.05 per share compared to 2017.

2017's results included a benefit of $0.03 per share from the remeasurement of the AWR parent deferred tax balances as a result of the tax reform. There were also higher state unitary taxes recorded in the parent level during 2018 as compared to the same period in 2017. I'll briefly discuss our liquidity for the year on this slide. Net cash provided by operating activity for 2018 was $136.8 million as compared to $144.6 million in 2017.

The decrease in cash from operating activities during 2018 was due primarily to significant differences in timing of income tax payments made, and refund received between the two periods and a decrease resulting from the timing of billings of and cash receipts for construction work at military bases during 2018. Golden State Water invested $121 million in company-funded capital projects in 2018, continuing our strong investment level. We expect to invest $115 million to $125 million in 2019. Golden State Water has a $40 million note, which will come due in March.

We intended to utilize our intercompany borrowing arrangements to repay this note next month and possibly issue additional long-term debt later this year. In May of 2018, we successfully renewed AWR's credit facility of $150 million for another five years, with an option to increase it by $50 million. This is to provide funds to both Golden State Water and ASUS in supporting their operations and growth. We received more favorable pricing terms than the prior arrangements.

At this time, we do not expect American States Water to issue additional equity. With that, I'll turn the call back to Bob.

Bob Sprowls -- President and Chief Executive Officer

Thank you, Eva. I'd like to provide an update on our recent regulatory activity. The settlement in the water general rate case application resolved all issues and authorizes Golden State Water to invest $334.5 million in capital infrastructure over the three-year rate cycle. This includes $20.4 million of capital projects to be filed for revenue recovery through advice letters when those projects are completed.

Excluding the advice letter project revenues, the water gross margin for 2019 in the settlement filing is expected to increase by approximately $6 million as compared to the 2018 adopted gross margin. However, the 2019 water revenue requirement and gross margin as settled have been reduced for a decrease of approximately $7 million in depreciation expense compared to the adopted 2018 depreciation expense due to a reduction in the overall composite depreciation rates based on a revised study filed in the general rate case. The decrease in depreciation expense as settled lowers the Water gross margin and is offset by a corresponding decrease in depreciation expense, resulting in no impact to net earnings. In addition, the 2019 water revenue requirement as settled includes a decrease of approximately $2.2 million for excess deferred tax refunds as a result of tax reform, which has its corresponding decrease in income tax expense and also results in no impact to earnings.

Had depreciation expense had settled remained the same as 2018 adopted amount and there were no excess deferred tax refunds that lowered the 2019 revenue requirement, the settled water gross margin for 2019 would have increased by approximately $15.2 million. The settlement as filed also allows for potential additional water revenue increases in 2020, in 2021, of approximately $10 million and $12 million, respectively, subject to the result of an earnings test and changes to the forecasted inflationary index values. We expect the CPUC to issue a proposed decision for this general rate case during the first quarter of 2019. When approved, the new water rates will be retroactive to January 1, 2019.

Our electric rate case was filed in May 2017 to set rates for years 2018 through 2021. In November 2018, Golden State Water and the Public Advocates Office filed a joint motion to adopt the settlement agreement between the two parties resolving all issues in connection with the general rate case. Among other things, the settlement extends the rate cycle by one year through 2022 and authorizes Golden State Water to construct all the capital projects requested in its application and increase for the addition of a fifth year in the rate cycle, which are dedicated to improving system safety and reliability and total approximately $44 million over the five-year rate cycle. As we discussed earlier, had the new rates in the settlement agreement been approved by the CPUC prior to December 31, 2018, the Electric segment's gross margin would have increased by approximately $2 million or $0.04 per share for 2018.

We will record the 2018 increase to earnings in the period in which a CPUC decision is received. It is possible but unlikely that the CPUC will issue decisions inconsistent with the filed joint settlements in the water and electric rate cases. Let's move on to ASUS on Slide 16. 2018 marks the highest annual earnings per share contribution from ASUS ever.

We were awarded our first military contract in 2004 and today, we have eight contracts. Earnings per share in 2018 for ASUS were $0.07 per share higher than 2017, excluding the retroactive revenues received in 2017 related to prior years. Major contributors to the higher earnings were the commencement of operations at Fort Riley in July and a full year of operations at Eglin Air Force Base. There was also an increase in management fee revenue at the other military bases, resulting from successful resolution of various price adjustments during 2017 and 2018.

We continue to work with the U.S. government for contract modifications related to potential capital upgrade work for improvement of water and wastewater infrastructure at the military bases we serve. During 2018, the U.S. government awarded ASUS $24 million in new construction projects, compared to $20.2 million in 2017, the majority of which are expected to be completed through 2019.

Completion of filings for economic price adjustments, Request for Equitable Adjustment, asset transfers and contract modifications awarded for new projects provide ASUS with additional revenues in dollar margin. We are still involved in various stages of the proposal process at a number of other bases considering privatization. The U.S. government is expected to release additional bases for bidding over the next several years.

Due to our strong relationship with the U.S. government, as well as our expertise and experience in managing bases, we are well-positioned to compete for these new contracts. Taking into account the $24 million in new construction projects awarded in 2018, initial upgrade work at Eglin Air Force Base and operating Fort Riley for a full year, we reaffirm our previous guidance of $0.43 to $0.47 per share for ASUS's 2019 earnings contribution. I'd like to turn our attention to dividends outlined on Slide 17.

The board of directors recently approved a first quarter dividend of $0.275 per share on the common shares of the company. American States Water Company has paid dividends to shareholders every year since 1931, increasing the dividends received by shareholders each calendar year for 64 consecutive years, which places it in an exclusive group of companies on the New York Stock Exchange that have achieved that result. The company's current dividend policy is to achieve a compound annual growth rate and a dividend of more than 6% over the long term. I'd like to conclude our prepared remarks this morning by thanking you for your interest in American States Water, and we'll now turn the call over to the operator for questions. 

Questions and Answers:

Operator

[Operator instructions] Our first question comes from Durgesh Chopra of Evercore ISI.

Durgesh Chopra -- Evercore ISI -- Analyst

Just quickly in terms like when we're looking '19 and '20, Eva, could you help us with how should we be modeling the effective tax rates? And then are you a cash tax payer currently, yes or no? And what does that look like into maybe 2021?

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

Yes. I think the effective tax rate, I think if you use the -- we have a note in our 10-K talk about 2018. If you look at note 11, it will tell you roughly what the ETR is for '18 and what's for '17. So it kind of gives you a good estimate going forward there.

What was your second question, I'm sorry?

Bob Sprowls -- President and Chief Executive Officer

Are we a cash tax payer? We are.

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

Yes, we are. We are.

Durgesh Chopra -- Evercore ISI -- Analyst

And does that tie up pretty closely to your effective tax rate? Or I mean, I'm just trying to get a sense of whether it is material or not.

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

A little different because there's always timing differences between book and taxes, so it's deferred, so it's not exactly tied to the provision. But you always have to consider the timing differences, that's where you have the different tax liabilities and assets there on our book.

Durgesh Chopra -- Evercore ISI -- Analyst

OK. Perfect. And then just a big-picture question, Bob. Like, I mean, say 2018 to 2017, looks like it's sort of, on an adjusted basis, nice growth year for you, gained predominantly just on the sort of the contracted services side.

Are you -- like, is there -- as we think long term, are you targeting a specific regulated versus non-regulated business mix? How do you think about that?

Bob Sprowls -- President and Chief Executive Officer

Well, to be honest, we're trying to grow both businesses. I do believe the Contracted Services business, probably in the next five-plus years, will grow a bit more quickly than the water utility business, so we might see ASUS represent a little bit higher proportion of the total consolidated earnings than they have historically. But I don't see us ever sort of getting to the point where it would be 40% to 50% of total company earnings because we are going to be growing a lot of the utility business over time as well.

Operator

Our next question comes from Richard Verdi of Coker & Palmer.

Richard Verdi -- Coker and Palmer Inc. -- Analyst

I'm quite clear on everything, good -- and by the way, it was a good quarter. I just have a couple of quick questions here. For the ASUS unit, thinking back to last year, there was some discussion due to tax reform that this military base division might have to pass through some of that tax benefit to the military bases and that was kind of offset by some thinking that, well, it's a contractual obligation where the military gets to keep a benefit to them and American States would get to keep a benefit. And so that's also then kind of offset by the thinking of, well, if you want to keep a good relationship with the military bases, you also might want to pass through some of these tax reform benefits that the company is seeing.

So with all of that long-winded commentary in mind, how should we think about taxes for ASUS going forward? Are you guys going to pass through some of this? Do you get to keep it all? I mean, how do we think about this moving forward?

Bob Sprowls -- President and Chief Executive Officer

Yes. So Richard, for our company, the benefit of tax reform has sort of been negotiated contract by contract with the U.S. government, and the changes have not really, at this point, been material, which means a good portion of the benefit is sort of going back to the customer. We do have one contract remaining where we haven't negotiated the benefit at this point.

Richard Verdi -- Coker and Palmer Inc. -- Analyst

OK, OK So would it be fair, Bob, from a -- and thank you for that -- from a modeling perspective, to kind of think, OK, well, everything for the most part has been passed through expect for that last little wrinkle?

Bob Sprowls -- President and Chief Executive Officer

At this point, except for the one contract, but it is a -- it's not a little contract, I'll let you know that.

Richard Verdi -- Coker and Palmer Inc. -- Analyst

OK, OK. Fair enough, fair enough.

Bob Sprowls -- President and Chief Executive Officer

We're still negotiating that and perhaps, we'll have a little more clarity when we talk in a couple of months.

Richard Verdi -- Coker and Palmer Inc. -- Analyst

OK, OK, perfect. All right. And then just one other question, too and it's on the acquisition front. Legislation across the country is becoming more and more supportive of privatization.

And in your prepared remarks that had stated, Bob, that the company wants to remain right on course where it is currently. And I don't blame you. I mean, the stock was up 16% last year, it's doing very well. But with legislation becoming so supportive and you think the two of your larger peers, they're doing quite well from the acquisition front, and they expect to continue to do well.

And then in addition to that, I mean, you guys know that I'm also active with the NAWC and Rob Powelson has taken over there, and he's kind of refocused that group to more of a local level instead of a federal level, getting it out of the DC level and into that local level. And so that should be more supportive of favorable legislation, that would be supportive of acquisitions and what have you. And so I'm kind of wondering, do you guys -- is there any thought to maybe possibly going out there and acquiring some municipalities possibly in other states? And then the offset to that is, of course, the company captures a higher multiple because you are based in California, right? And so I was just wondering if you could give me some sort of thought process about how American States thinks about the acquisition front and balances that against the California backdrop, and if you guys will participate in the acquisitions.

Bob Sprowls -- President and Chief Executive Officer

Well, we are always looking for acquisitions. We have not sort of been as, I would say, as aggressive as the Aquas of the world in terms of making bids for municipalities that are not for sale, to try to entice them to come to the table. I would say, for us to acquire a municipality outside of California, it would need to be substantial enough in terms of number of customers for us to be able to influence the regulatory policy in the state. So we would need to -- and as you know, regulatory policy is a state-by-state approach.

Some states are much stronger on the regulatory front than others, so it would need to be at a state that's got, we would say, a progressive or at least payor regulation. But we're not opposed to going out and doing acquisitions out of California, but it would have to be in a state where we can sort of get a large enough presence to be able to influence the regulatory policy.

Operator

[Operator instructions] Our next question comes from Jonathan Reeder of Wells Fargo.

Jonathan Reeder -- Wells Fargo Securities -- Analyst

What was GSWC's earned regulatory ROE in 2018 versus the 8.9% allowed?

Bob Sprowls -- President and Chief Executive Officer

Yes. So the ROE that we earned from all of Golden State was 9.8% for 2018.

Jonathan Reeder -- Wells Fargo Securities -- Analyst

OK. And then can your mind us, are there like opportunities where you earn in excess of the allowed ROE on a like, consistent basis? I believe what shows up on your other income line for GSWC does not go into the earned ROE calculation. But are there other utility activities that flow through some of the other lines that also do not go into that earned ROE calculation?

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

I think for the recorded, Jonathan, we do include it in the earned ROE because even though it's not regulated. So that's part of our 9.8% that Bob just gave to you. So we do have some water lease under the nonregulated activity at the Golden State Water.

Jonathan Reeder -- Wells Fargo Securities -- Analyst

OK. So you're saying the 9.8% is on just the reported net income, basically?

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

Yes.

Bob Sprowls -- President and Chief Executive Officer

That's right.

Jonathan Reeder -- Wells Fargo Securities -- Analyst

OK. And then have proposed decisions been issued in either of those GRC cases, Bob?

Bob Sprowls -- President and Chief Executive Officer

They have not.

Jonathan Reeder -- Wells Fargo Securities -- Analyst

OK. But did you say you thought you would get a final decision on the Water one in Q1, meaning like a proposed decision should be imminent?

Bob Sprowls -- President and Chief Executive Officer

Well, I think what I said, we expect the proposed decision in the first quarter. But then when you time it out, there has to be 30 days between the proposed and the final. And then the commission doesn't have that many meetings between now and the end of March, so...

Jonathan Reeder -- Wells Fargo Securities -- Analyst

OK. And then the PD and electric case, I mean, do you think it will get done at least in Q2? Or who knows?

Bob Sprowls -- President and Chief Executive Officer

No. I would expect that in Q2, I would say it's a bit behind the Water GRC. It's just sort of -- that business is pretty small and it doesn't get pushed along quickly at the PUC because of its size, given the other issues that the PUC is dealing with these days.

Jonathan Reeder -- Wells Fargo Securities -- Analyst

Sure. There's a few big ones, right?

Bob Sprowls -- President and Chief Executive Officer

Yes.

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

And Jonathan, just a reminder for the [ B to E ], if we receive the final decision, we, of course, will reflect the '19 with the new rates. But we also will book the $0.04 that belongs to '18 that's retroactive to January 1, 2018. So if we receive that decision in '19, that will be booked in '19.

Jonathan Reeder -- Wells Fargo Securities -- Analyst

Right, OK. And then Eva, on the cash flow from operations, the past few years or two years at least benefited from the annual regulatory liability recovery that's been like $40 million to $50 million. Is that the WRAM MCBA balance recovery?

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

Mostly from the WRAM MCBA.

Jonathan Reeder -- Wells Fargo Securities -- Analyst

So then at the end of drought and the new rate case, hopefully should keep that deficit from growing significantly. How much longer should we be assuming like, additional cash recovery at that level? Can you remind us where the WRAM balance currently stands and everything?

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

I think for 2019, we incurred, I want to say, about...

Bob Sprowls -- President and Chief Executive Officer

2018.

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

2018, about $9 million on the collection of the WRAM MCBA. So if you give me a moment now, let me tell you what the balance is in note three of our 10-K, page, sorry. So we still -cumulative balance for WRAM and MCBA right now is at about $18 million, which including a portion of the prior year and of course, what's incurred in '18. And we will file a surcharge recovery next month, early next month to recover the 2018 balance.

Jonathan Reeder -- Wells Fargo Securities -- Analyst

OK. So the $18 million kind of assumed recovery over maybe like a two-year period, which implies I guess, cash flow from operations in '19 probably has a step-down from what we saw in '18. Is that accurate?

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

Yes, maybe a little bit. We usually recover between 12 to 18 months because the balance has decreased as compared to the prior years. So recover between 12 to 18 months is a reasonable period, Jonathan.

Operator

[Operator instructions] As we have no further questions, this concludes our question-and-answer session. I would like to turn the conference back over to Mr. Bob Sprowls for any closing remarks.

Bob Sprowls -- President and Chief Executive Officer

Thank you, Nicole. And thank you all for your participation today, and we look forward to speaking with you next quarter.

Operator

[Operator signoff]

Duration: 47 minutes

Call Participants:

Bob Sprowls -- President and Chief Executive Officer

Eva Tang -- Senior Vice President of Finance and Chief Financial Officer

Durgesh Chopra -- Evercore ISI -- Analyst

Richard Verdi -- Coker and Palmer Inc. -- Analyst

Jonathan Reeder -- Wells Fargo Securities -- Analyst

More AWR analysis

This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.

10 stocks we like better than American States WaterWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and American States Water wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of February 1, 2019

Wednesday, February 27, 2019

3 Arguments for and Against Buying Tilray

The marijuana industry is transforming at a rapid pace. What had once been considered a taboo and highly risky investment arena is now a legitimate business model that's rolling out the red carpet for investors. By 2022, according to Arcview Market Research and BDS Analytics, global weed sales could hit north of $31 billion, which would represent more than a tripling from global cannabis sales in 2017.

It's no longer a matter of whether the marijuana industry will survive. Now, it's a question of which companies will thrive.

A tipped over bottle filled with dried cannabis buds sitting next to a messy pile of cash bills.

Image source: Getty Images.

In 2018, arguably no company ascended to the heavens faster than Tilray (NASDAQ:TLRY), which became the first Canadian pot stock to go the initial public offering route on a major U.S. exchange. In a two-month span, Tilray's share price ran from its list of $17 per share to an intraday peak of $300. It was like the dot-com era all over again. Even after having given back three-quarters of its gains since hitting $300 on an intraday basis, it's still either the second- or third-most valuable pot stock by market cap, depending on where it and Aurora Cannabis are trading any given day.

But the bigger question is, should Tilray be on your buy list? With valid arguments on both sides of the aisle, let's take a closer look.

Three reasons Tilray could make you a marijuana millionaire

Possibly the top reason Tilray should be considered as a long-term buy is the company's ability to attract brand-name partnerships. Whereas peers such as Aurora Cannabis and Aphria are still struggling to land a major partner in the beverage, tobacco, or pharmaceutical industries, Tilray has managed to nab a partner from two out of three of these industries.

In December, Tilray announced a global distribution partnership with Novartis' generic-drug subsidiary, Sandoz, for non-combustible cannabis products. This was actually more of an expansion of an agreement already in place with Sandoz from earlier in 2018, whereby Novartis' subsidiary would act as a distributor within Canada.

Also in December, Tilray formed a $100 million joint venture with Anheuser-Busch InBev (NYSE:BUD). Tilray and Anheuser-Busch InBev will put up $50 million each to research and develop cannabis-infused beverages, which are expected to be legalized by no later than mid-October 2019. This was an especially powerful win for Tilray, given that Anheuser-Busch InBev CEO Carlos Brito had no intention of entering the pot market as recently as June 2018.

Four vials of cannabidiol oil lined up on a counter.

Image source: Getty Images.

Second, investors will appreciate the company's brand-name medical marijuana products, as well as its push to diversify into higher-margin cannabis alternatives. Whereas dried cannabis flower is the best known sellable product, it tends to carry the lowest margins relative to other pot products because of oversupply and commoditization over time. Tilray's focus on medical marijuana research, cannabis oils, hemp, and other alternative products that are geared at medical marijuana consumers should lead to superior long-term margins. And, as noted, being one of the first licensed producers has allowed Tilray plenty of time to build up its brands and improve consumer engagement.

Third and finally, it's a positive that private-equity firm Privateer Holdings owns close to 80% of all outstanding shares of Tilray. Having one gigantic presence backing this stock demonstrates that folks with money expect it to execute on its long-term strategy.

Three valid arguments why Tilray could be toxic to your portfolio

However, there are also reasons to believe Tilray could completely flop.

One of the biggest red flags with Tilray is that its production isn't anywhere near on par with its larger peers, and management has yet to say much about what the next steps are with regard to expansion.

Before the company went public, Tilray released plenty of details in its S-1 prospectus filing with the Securities and Exchange Commission. As of June 2018, the company expected to have 912,000 square feet of facilities developed by the end of 2018, with just over 850,000 square feet devoted to growing space. The problem is this might only yield around 80,000 kilograms annually, whereas Canopy Growth, Aurora Cannabis, and Aphria should produce around 500,000, 700,000, and 255,000 kilos, respectively, at peak output. Tilray simply isn't on par with its peers in the production department, and despite having close to 3 million square feet of expansion space, it has yet to divulge any specifics of what's next in terms of capacity expansion.

A businessman in a suit pressing the sell button on a digital screen.

Image source: Getty Images.

Second, having Privateer as a major shareholder might also be bad news. When the company's lock-up expiration hit on Jan. 15, Tilray's stock took it on the chin and fell 17%. The scary thing is that only about 10% of the company's outstanding shares were actually available to be sold on that date by insiders, with Privateer Holdings issuing a statement that it wouldn't consider selling any of its stake until the second half of 2019. But if and when Privateer does sell some of its stake, it could seriously weigh down Tilray's share price.

Last, but not least, Tilray isn't anywhere close to turning an operating or bottom-line profit. There's no doubt that sales will spike notably higher following Canada's legalization of recreational marijuana and the company's push into hemp. But Tilray will be busy using its capital to research cannabis products, enter new markets, market its brands, and presumably expand its growing capacity. These higher expenses could easily keep Tilray in the red for years to come. That makes it off-limits for fundamentally focused investors.

Now that you've heard both sides of the story, all that's left to decide is whether Tilray belongs in your portfolio.

Tuesday, February 26, 2019

Could Geron Be a Millionaire-Maker Stock?

Last year, Geron's (NASDAQ:GERN) stock ripped higher in anticipation of Johnson & Johnson's (NYSE:JNJ) continuation decision revolving around the duo's experimental blood cancer drug imetelstat. However, the biotech's shares promptly gave back all of these annual gains -- and then some -- when J&J decided that imetelstat didn't fit into its long-term plans. 

Geron's epic fall late last year, though, might turn out to be a once-in-a-lifetime opportunity for patient investors. The hematology-oncology space, after all, is one of the most highly valued and fastest-growing areas in all of healthcare. Moreover, J&J reportedly didn't base its decision on imetelstat's clinical performance, but rather on a strategic portfolio review.

Close-up image of human blood.

Image Source: Getty Images.

This beaten-down biotech stock could thus turn out to be a hidden gem in the event that imetelstat's upcoming late-stage program is a success. Let's dig deeper to consider if risk-tolerant investors should take a flier on this penny biotech stock right now. 

Background and outlook

For those new to this story, J&J was evaluating imetelstat in two mid-stage trials for the blood disorders known as relapsed/refractory myelofibrosis and lower risk myelodysplastic syndromes, respectively. Following Geron's presentations at last year's American Society of Hematology meeting, we learned the following about these two studies: In patients with advanced myelofibrosis who have stopped responding or never responded to treatment with Incyte's Jakafi, imetelstat failed to reduce spleen volumes in a manner that would clearly indicate a strong therapeutic benefit in this patient group as a whole. 

That said, patients in this trial did yield an encouraging trend in terms of median overall survival, compared to those from other studies. Therefore, imetelstat might still have an important role to play in the treatment of patients no longer eligible for Incyte's front-line therapy. 

Unfortunately, Geron will probably need a partner to pursue this high-value indication. A pivotal study with overall survival as its primary endpoint could easily take three to four years to complete. And that kind of extensive development timeline is well beyond Geron's reach from a financial standpoint right now. 

Imetelstat's prospects in lower-risk myelodysplastic syndromes, however, appear to be much brighter. In short, the drug's midstage trial results for this second indication prompted Geron to move forward with a late-stage trial scheduled to get underway in mid-2019. If this next study is a success, imetelstat's commercial opportunity could be as high as $1.5 billion. 

Can Geron deliver a million-dollar payday?

With imetelstat's advanced myelofibrosis indication in question, investors should probably focus solely on the drug's prospects in myelodysplastic syndromes for the time being. But that's not all sunshine and unicorns, either. Acceleron Pharma and Celgene's luspatercept is likely to gain a first-mover advantage for this indication, which could cut deeply into imetelstat's peak sales opportunity.  

Even so, Geron's stock could still produce some astonishing returns on capital. For example, an investment of $10,000 at current levels has the potential to appreciate into something along the lines of $25,000 to $28,0000 in the next few years -- even if imetelstat ends up only grabbing 12% to 15% of the myelodysplastic syndromes market and Geron's stock garners at least an average premium. 

Bottom line: Although this penny biotech stock may not be one of the rare gems that can easily transform a small amount of capital into a million-dollar payday, there's arguably enough upside potential here to warrant a serious look by aggressive investors who are comfortable with heavy doses of risk.

 

Monday, February 25, 2019

Best Financial Stocks To Buy For 2019

tags:SKT,PCH,VLY,PUK,BNCL,STRS,

Image source: The Motley Fool.

Intl FCStone Inc  (NASDAQ:INTL)Q1 2019 Earnings Conference CallFeb. 07, 2019, 9:00 a.m. ET

Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

Operator

Good day, ladies and gentlemen, and welcome to INTL FCStone First Quarter Fiscal Year 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. (Operator Instructions). As a reminder, today's conference is being recorded.

I would now like to turn the call over to Bill Dunaway, CFO. Mr. Dunaway you may begin.

William J. Dunaway -- Chief Financial Officer

Good morning. My name is Bill Dunaway. Welcome to our earnings conference call for our fiscal first quarter ended December 31, 2018. After the market closed yesterday, we issued a press release reporting our results for the first fiscal quarter of 2019.

Best Financial Stocks To Buy For 2019: Tanger Factory Outlet Centers Inc.(SKT)

Advisors' Opinion:
  • [By Paul Ausick]

    Tanger Factory Outlet Centers Inc. (NYSE: SKT) traded down nearly 10% Wednesday and posted a new 52-week low of $21.14 after closing Tuesday at $23.47. The stock’s 52-week high is $34.76. Volume was around 6.9 million, nearly five times the daily average. The companr reported results after markets closed Tuesday.

  • [By Matthew Frankel, CFP®, Neha Chamaria, and Matthew DiLallo]

    With that in mind, there are some stocks that pay more than IBM that may be worth a look. These three Motley Fool contributors have their eyes on Tanger Factory Outlet Centers (NYSE:SKT), Dominion Energy (NYSE:D), and ONEOK (NYSE:OKE), and here's why:

  • [By Reuben Gregg Brewer]

    Today, ExxonMobil Corporation (NYSE:XOM), Tanger Factory Outlet Centers, Inc. (NYSE:SKT), and AT&T, Inc. (NYSE:T) are all offering big yields for investors willing to think long term.

  • [By Steve Symington]

    Tanger Factory Outlet Centers Inc. (NYSE:SKT) announced fourth-quarter 2018 results on Thursday after the market closed. The outlet-center real estate investment trust once again showcased its ability to keep its properties filled with motivated tenants and shoppers -- though some investors are less than pleased with its seemingly soft forward outlook.

  • [By Leo Sun]

    Shares of Tanger Factory Outlets (NYSE:SKT) fell 9% to an eight-year low on May 2 after the outlet owner reported its first quarter earnings. Tanger beat estimates on the top and bottom lines, but also reported declines in its core business and cut its full-year guidance.

  • [By Jeremy Bowman, Leo Sun, and Steve Symington]

    To take advantage of that potential boom, we asked three of our retail writers for their top picks for May. See why they recommend Dollar General (NYSE:DG), Tanger Factory Outlet Centers (NYSE:SKT), and Home Depot (NYSE:HD).

Best Financial Stocks To Buy For 2019: Potlatch Corporation(PCH)

Advisors' Opinion:
  • [By Stephan Byrd]

    Shares of Potlatchdeltic Corp (NASDAQ:PCH) have received an average recommendation of “Hold” from the nine ratings firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $49.60.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Potlatchdeltic (PCH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Itau Unibanco Holding S.A. bought a new position in Potlatchdeltic Corp (NASDAQ:PCH) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 4,644 shares of the real estate investment trust’s stock, valued at approximately $236,000.

  • [By Stephan Byrd]

    Teachers Insurance & Annuity Association of America bought a new position in PotlatchDeltic (NASDAQ:PCH) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 78,505 shares of the real estate investment trust’s stock, valued at approximately $4,086,000. Teachers Insurance & Annuity Association of America owned approximately 0.19% of PotlatchDeltic at the end of the most recent reporting period.

Best Financial Stocks To Buy For 2019: Valley National Bancorp(VLY)

Advisors' Opinion:
  • [By Stephan Byrd]

    Valley National Bank (NYSE:VLY) announced a quarterly dividend on Tuesday, May 22nd, RTT News reports. Stockholders of record on Friday, June 15th will be paid a dividend of 0.11 per share by the financial services provider on Tuesday, July 3rd. This represents a $0.44 annualized dividend and a dividend yield of 3.39%.

  • [By Shane Hupp]

    New Mexico Educational Retirement Board reduced its position in Valley National Bancorp (NYSE:VLY) by 14.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 62,100 shares of the financial services provider’s stock after selling 10,700 shares during the quarter. New Mexico Educational Retirement Board’s holdings in Valley National Bancorp were worth $755,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Ethan Ryder]

    Swiss National Bank lifted its position in Valley National Bank (NYSE:VLY) by 21.0% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 544,300 shares of the financial services provider’s stock after purchasing an additional 94,600 shares during the period. Swiss National Bank owned about 0.16% of Valley National Bank worth $6,782,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Shane Hupp]

    Valley National Bancorp (NYSE:VLY) has been assigned a consensus rating of “Hold” from the nine brokerages that are covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating on the company. The average 12-month price target among analysts that have covered the stock in the last year is $13.96.

  • [By Stephan Byrd]

    Valley National Bancorp (NYSE:VLY) – Investment analysts at Piper Jaffray Companies cut their Q3 2019 earnings per share (EPS) estimates for Valley National Bancorp in a research note issued on Monday, February 4th. Piper Jaffray Companies analyst M. Breese now expects that the financial services provider will post earnings of $0.24 per share for the quarter, down from their previous forecast of $0.25. Piper Jaffray Companies also issued estimates for Valley National Bancorp’s Q4 2019 earnings at $0.24 EPS, FY2019 earnings at $0.95 EPS, Q1 2020 earnings at $0.25 EPS, Q2 2020 earnings at $0.26 EPS, Q3 2020 earnings at $0.26 EPS, Q4 2020 earnings at $0.26 EPS and FY2020 earnings at $1.04 EPS.

Best Financial Stocks To Buy For 2019: Prudential Public Limited Company(PUK)

Advisors' Opinion:
  • [By Ethan Ryder]

    ValuEngine lowered shares of Prudential (NYSE:PUK) from a buy rating to a hold rating in a research note issued to investors on Wednesday morning.

    Several other analysts have also recently issued reports on the stock. Zacks Investment Research upgraded shares of Prudential from a hold rating to a buy rating and set a $57.00 target price on the stock in a research note on Tuesday, March 27th. Berenberg Bank cut shares of Prudential from a hold rating to a sell rating in a research note on Thursday, March 29th. Finally, Citigroup cut shares of Prudential from a buy rating to a neutral rating in a research note on Wednesday, April 25th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company. The stock currently has an average rating of Hold and an average price target of $57.00.

  • [By Stephan Byrd]

    Here are some of the news headlines that may have effected Accern’s rankings:

    Get Prudential alerts: Zacks Investment Research Lowers Prudential (PUK) to Hold (americanbankingnews.com) Financial wellness program popularity rises among employers, up 63 percentage points in two years (markets.financialcontent.com) FY2018 EPS Estimates for Prudential (PUK) Reduced by Jefferies Group (americanbankingnews.com) Jefferies Group Weighs in on Prudential’s FY2020 Earnings (PUK) (americanbankingnews.com) ValuEngine Downgrades Prudential (PUK) to Hold (americanbankingnews.com)

    Shares of PUK stock traded down $0.02 during trading on Tuesday, hitting $51.56. 141,455 shares of the stock traded hands, compared to its average volume of 198,097. The firm has a market cap of $66.49 billion, a PE ratio of 13.79, a PEG ratio of 1.34 and a beta of 1.55. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.03 and a current ratio of 0.03. Prudential has a 52-week low of $44.49 and a 52-week high of $55.36.

  • [By Ethan Ryder]

    Prudential (NYSE: PUK) and Reinsurance Group of America (NYSE:RGA) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership.

  • [By Joseph Griffin]

    Prudential Public Limited (NYSE:PUK) has earned a consensus recommendation of “Hold” from the six analysts that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company.

Best Financial Stocks To Buy For 2019: Beneficial Mutual Bancorp Inc.(BNCL)

Advisors' Opinion:
  • [By Ethan Ryder]

    BidaskClub upgraded shares of Beneficial Bancorp (NASDAQ:BNCL) from a sell rating to a hold rating in a report released on Tuesday morning.

    Shares of Beneficial Bancorp opened at $16.35 on Tuesday, MarketBeat.com reports. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $1.23 billion, a P/E ratio of 31.44 and a beta of 0.55. Beneficial Bancorp has a fifty-two week low of $14.40 and a fifty-two week high of $17.50.

  • [By Logan Wallace]

    Beneficial Bancorp (NASDAQ: BNCL) and Home Bancorp (NASDAQ:HBCP) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.

  • [By Ethan Ryder]

    Entegra Financial (NASDAQ: BNCL) and Beneficial Bancorp (NASDAQ:BNCL) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends and institutional ownership.

Best Financial Stocks To Buy For 2019: Stratus Properties Inc.(STRS)

Advisors' Opinion:
  • [By Shane Hupp]

    Here are some of the media stories that may have impacted Accern Sentiment’s analysis:

    Get Stratus Properties alerts: Analyzing Stratus Properties (STRS) & City Developments (CDEVY) (americanbankingnews.com) Stratus Properties (STRS) versus City Developments (CDEVY) Financial Survey (americanbankingnews.com) Reviewing Stratus Properties (STRS) and St. Joe (JOE) (americanbankingnews.com) Stratus Properties (STRS) versus City Developments (CDEVY) Head-To-Head Analysis (americanbankingnews.com) Contrasting Stratus Properties (STRS) & St. Joe (JOE) (americanbankingnews.com)

    NASDAQ STRS traded down $0.25 during trading hours on Monday, hitting $31.10. The company’s stock had a trading volume of 528 shares, compared to its average volume of 7,123. Stratus Properties has a 52 week low of $26.15 and a 52 week high of $32.15. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 1.74.

Thursday, February 21, 2019

UK Government To Fund AI University Courses With £115m

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-1130252398&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1130252398/960x0.jpg?fit=scale&q; data-height=&q;705&q; data-width=&q;960&q;&g; Aerial view of the city of Cambridge, UK

&l;/p&g;&l;p class=&q;p1&q;&g;The UK government is planning to fund thousands of postgraduate students that want to study a Masters or a PhD in artificial intelligence as it looks to keep pace with the US and China.&l;/p&g;

&l;p class=&q;p1&q;&g;AI is poised to become the most significant technology for&a;nbsp;a generation but there are only so many people that know how to develop the technology, which could have a huge impact on industries such as healthcare, energy, and automotive.&l;/p&g;

&l;p class=&q;p1&q;&g;Business Secretary Greg Clark and Digital Secretary Jeremy Wright &l;a href=&q;https://www.gov.uk/government/news/next-generation-of-artificial-intelligence-talent-to-be-trained-at-uk-universities&q; target=&q;_blank&q;&g;announced on Thursday&l;/a&g; that the government will commit up to &a;pound;115 million towards training the next generation of AI talent.&l;/p&g;

&l;p class=&q;p1&q;&g;In a press release, the government said 1,000 students will&a;nbsp;receive funding to enable them to complete PhDs at 16 UK Research and Innovation AI Centres for Doctoral Training (CDTs), located across the country. The full list of centres can be found at the end of this article.&l;/p&g;

&l;p class=&q;p1&q;&g;A cohort of businesses &a;mdash; including Google DeepMind, BAE Systems and Cisco &a;mdash; have also pledged to help fund 200 new AI masters courses at UK universities.&l;/p&g;

&l;p class=&q;p1&q;&g;Five new research fellowships are also being created in collaboration with the Alan Turing Institute in a bid to retain and attract top AI talent in UK academic institutions.&l;/p&g;

&l;p class=&q;p1&q;&g;According to &l;a href=&q;https://www.ukri.org/news/200m-to-create-a-new-generation-of-artificial-intelligence-leaders/&q; target=&q;_blank&q;&g;government quango UK Research &a;amp; Innovation&l;/a&g;, industry partners will commit &a;pound;78 million, while partner universities are committing a further &a;pound;23 million. That brings total funding to over &a;pound;200 million.&l;/p&g;

&l;p class=&q;p1&q;&g;Business Secretary Greg Clark said in a statement:&l;/p&g;

&l;blockquote&g; &l;p class=&q;p1&q;&g;&q;The UK has long been a nation of innovators. This AI skills and talent investment will help nurture leading UK and international talent to ensure we retain our world-beating reputation in research and development.&l;/p&g; &l;p class=&q;p1&q;&g;&q;Artificial intelligence has great potential to drive up productivity and enhance every industry throughout our economy, from more effective disease diagnosis to building smart homes. Today&a;rsquo;s announcement is our modern Industrial Strategy in action, investing in skills and talent to drive high skilled jobs, growth and productivity across the UK.&q;&l;/p&g; &l;/blockquote&g;

&l;p class=&q;p1&q;&g;Figures compiled by analysis firm Dealroom show that&a;nbsp;&l;span&g;the number of venture capital investments into the UK&a;rsquo;s rapidly growing&a;nbsp;&l;/span&g;&l;abbr title=&q;artificial intelligence&q;&g;AI&l;/abbr&g;&l;span&g;&a;nbsp;sector soared by 17% last year.&a;nbsp;In total, &a;pound;998 million was invested in the UK&s;s AI sector.&a;nbsp;&l;/span&g;&l;/p&g;

&l;p class=&q;p1&q;&g;&l;span&g;&l;/span&g;&l;strong&g;AI doctoral training centres&l;/strong&g;&l;strong&g;:&l;/strong&g;&l;/p&g;

&l;p class=&q;p1&q;&g;1. Foundational Artificial Intelligence (Led by Professor David Barber, &l;strong&g;UCL&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;2. AI-enabled Healthcare Systems (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Geraint Rees, &l;strong&g;UCL&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;3. Data Science and AI for Sustainable Futures (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Gavin Shaddick, &l;strong&g;University of Exeter&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;4. Natural Language Processing (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Mirella Lapata, &l;strong&g;University of Edinburgh&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;5. Artificial Intelligence and Music (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Simon Dixon, &l;strong&g;Queen Mary University of London&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;6. Speech and Language Technologies and their Applications (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Thomas Hain, &l;strong&g;University of Sheffield&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;7. Artificial Intelligence for Healthcare (&l;span&g;Led&a;nbsp;&l;/span&g;by&a;nbsp;Dr Aldo Faisal, &l;strong&g;Imperial College London&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;8. Accountable, Responsible and Transparent AI (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Eamonn O&s;Neill, &l;strong&g;University of Bath&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;9. Artificial Intelligence, Machine Learning and Advanced Computing (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Gert Aarts, &l;strong&g;Swansea University&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;10. Machine Intelligence for Nano-electronic Devices and Systems (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Tim Norman, &l;strong&g;University of Southampton&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;11. Biomedical Artificial Intelligence (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Guido Sanguinetti, &l;strong&g;University of Edinburgh&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;12. Training in Social Intelligent Artificial Agents (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Alessandro Vinciarelli, &l;strong&g;University of Glasgow&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;13. Centre for Doctoral Training in Interactive Artificial Intelligence (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Peter Flach, &l;strong&g;University of Bristol&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;14. Application of Artificial Intelligence to the study of Environmental Risks (AI4ER) (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Simon Redfern, &l;strong&g;University of Cambridge&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;15. Safe and Trusted Artificial Intelligence (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor Michael Luck, &l;strong&g;King&s;s College London&l;/strong&g;)&l;/p&g;

&l;p class=&q;p1&q;&g;16. Artificial Intelligence for Medical Diagnosis and Care (&l;span&g;Led&a;nbsp;&l;/span&g;by&l;span&g;&a;nbsp;&l;/span&g;Professor David Hogg, &l;strong&g;University of Leeds&l;/strong&g;)&l;/p&g;

Wednesday, February 20, 2019

This Is By Far the Biggest Catalyst for Marijuana Stocks in 2019

This site uses Akismet to reduce spam. Learn how your comment data is processed.

The cannabis market is estimated to grow close to $150 billion by 2025. This meant strides for weed stocks last year, but signals even greater upside for marijuana stocks in 2019.

marijuana stocks in 2019Many still see marijuana in terms of its recreational use, but they're missing an entire emerging, lucrative market centered on its wellness and healing applications.

Cannabidiol, or CBD, is a non-hallucinogenic compound derived from the marijuana plant. Because CBD lacks the hallucinogenic properties of THC, it has become widely used to support pain relief, treatment of disease symptoms, and overall wellness.

CBD is all natural and shows huge promise for the treatment of post-traumatic stress disorder, schizophrenia, and several other conditions. It has become popular among people suffering from arthritis and chronic fatigue – it has even helped arthritic dogs and cats!

We believe CBD vendors will be among the best marijuana stocks of 2019, but there's one stock poised to land on top. Before we reveal our stock pick, here's why 2019 will be the year of CBD…
THREE STATES just legalized marijuana, and these three stocks could potentially see a 1,000% boost. Click here to learn more…

What It Looks Like for Marijuana Stocks In 2019

Money Morning Director of Cannabis Investing Research Greg Miller believes this year will go down in the history books as "the year of CBD."

Research firm Brightfield Group agrees, projecting CBD as a $2 billion market in 2019 – and $22 billion by 2022.

Loosening restrictions on marijuana and hemp are largely responsible for this continued growth.

Hemp was only made legal at the federal level in December 2018. Today, farmers of hemp can access banking services, insurance for crops, and even U.S. research grants that were only recently unavailable. Because banks and insurance firms are both regulated at the federal level, they were not willing to do business with marijuana growers until now.

Last year, the website Marijuana Moment followed 915 U.S. federal and state bills concerning marijuana, medical marijuana, and hemp. At least 147 of those were signed or enacted.

So far in 2019, state legislators and U.S. congressional representatives have filed over 350 proposals related to pot.

Legalization is even becoming a global phenomenon, as the United Nations plans to de-schedule CBD, whether it comes from hemp or marijuana plants.

Many cannabis companies await further legalization, knowing demand will grow as more hemp and marijuana products are legalized.

Meanwhile, new applications for CBD continue to be found: skin moisturizers, honey, coffee, beer, nutrition bars, gummies, and energy shots.

The burgeoning product list, combined with the rising acceptance of weed and CBD, will lead to increased distribution. This is great news for marijuana stocks in 2019 – especially this one in particular, expected to partner with several global brands to put its product on the map…

Watch This Marijuana Stock in 2019

Join the conversation. Click here to jump to comments…

Tuesday, February 19, 2019

Top 5 Biotech Stocks To Invest In Right Now

tags:ALNY,BIIB,AMGN,ARQL,

It was a decision a long time in the making, but the Food and Drug Administration has officially given Portola Pharmaceuticals' (NASDAQ:PTLA) AndexXa the green light. The approval ends a winding road for the company that includes a regulatory rejection, a refiling for approval, and requests for additional information. With a go-ahead finally secured, is this biotech about to become a top stock to buy?

In this clip from The Motley Fool's Industry Focus: Healthcare, analysts Kristine Harjes and Todd Campbell discuss why AndexXa matters to this company's investors.

A full transcript follows the video.

This video was recorded on May 9, 2018.

Kristine Harjes: We want to update you guys about Portola! [laughs] I hope our listeners aren't sick of hearing us talk about this. I was thinking about it earlier today, I knew that we were going to be talking about Portola, and I wish we could make a metric that had captured a ratio between the number of minutes that we've spent discussing a stock on this show relative to that stock's market cap, because Portola would be by far the highest. [laughs]

Top 5 Biotech Stocks To Invest In Right Now: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors' Opinion:
  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    So, which biotech stocks should you consider buying in June? That's a question we posed to three of our healthcare-focused investors. Interestingly enough, mid-cap biotech stocks are the clear flavor of the month. If biotech is on your radar in June, our investors suggest you consider Ionis Pharmaceuticals (NASDAQ:IONS), Spark Therapeutics (NASDAQ:ONCE), and Alnylam Pharmaceuticals (NASDAQ:ALNY).

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) updated investors last month on how the launch of Onpattro, its first drug that was approved to treat transthyretin-mediated amyloidosis (ATTR), was going at the J.P. Morgan Healthcare Conference.

  • [By Jim Crumly]

    Drug giant Pfizer released details of a successful trial of a drug for heart damage from a rare disease, and although that company's stock had little reaction, falling 1.9%, shares of companies with potentially competing drugs reacted sharply. Alnylam Pharmaceuticals (NASDAQ:ALNY) soared 16.2%, Ionis Pharmaceuticals (NASDAQ:IONS) jumped 7.8%, and Eidos Therapeutics (NASDAQ:EIDX) plunged 31.1%.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Alnylam Pharmaceuticals (ALNY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Biotech Stocks To Invest In Right Now: Biogen Idec Inc(BIIB)

Advisors' Opinion:
  • [By Chris Lange]

    Short interest in Biogen Inc. (NASDAQ: BIIB) increased to 4.33 million shares from the previous 3.86 million. The stock recently traded at $306.68 within a 52-week range of $249.17 to $370.57.

  • [By Chris Lange]

    Short interest in Biogen Inc. (NASDAQ: BIIB) increased to 4.00 million shares from the previous 3.91 million. The stock recently traded at $346.90, within a 52-week range of $249.17 to $388.67.

  • [By Keith Speights]

    Ionis has solid revenue coming in the door thanks to Spinraza. Biogen (NASDAQ:BIIB) markets the spinal muscular atrophy (SMA) drug, but Ionis receives royalties on all sales. In Q1, those royalties totaled $41 million, up from $5 million in the prior-year period. 

  • [By Stephan Byrd]

    Traders bought shares of Biogen Inc (NASDAQ:BIIB) on weakness during trading on Tuesday. $119.44 million flowed into the stock on the tick-up and $86.88 million flowed out of the stock on the tick-down, for a money net flow of $32.56 million into the stock. Of all companies tracked, Biogen had the 26th highest net in-flow for the day. Biogen traded down ($7.15) for the day and closed at $345.41

  • [By Chris Lange]

    Short interest in Biogen Inc. (NASDAQ: BIIB) decreased to 3.45 million shares from the previous 3.50 million. The stock recently traded at $274.50, within a 52-week range of $244.28 to $370.57.

  • [By Keith Speights]

    Investors haven't been happy with either Biogen (NASDAQ:BIIB) or Celgene (NASDAQ:CELG) lately. But the level of discontent is much higher with Celgene. The biotech stock has dropped more than 20% so far in 2018, compared to a single-digit percentage decline for Biogen.

Top 5 Biotech Stocks To Invest In Right Now: Amgen Inc.(AMGN)

Advisors' Opinion:
  • [By ]

    Amgen's (NASDAQ:AMGN) past is filled with excitement. The company rose to become one of the biggest biotechs in the world. It grew a product lineup with multiple blockbuster drugs. Over the last decade, Amgen's share price has more than tripled. But the excitement appears likely to diminish considerably for Amgen -- at least for the next few years.

  • [By Logan Wallace]

    Navellier & Associates Inc lifted its holdings in Amgen, Inc. (NASDAQ:AMGN) by 1.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,176 shares of the medical research company’s stock after purchasing an additional 353 shares during the period. Navellier & Associates Inc’s holdings in Amgen were worth $4,278,000 at the end of the most recent reporting period.

  • [By ]

    Amgen (Nasdaq: AMGN) -- Amgen is a leading global biotech developer with a diverse product portfolio and promising development pipeline. The company has special expertise in cancer research and renal failure (kidney disease) treatments. Its biggest blockbuster is the anti-inflammatory drug Enbrel, used primarily for rheumatoid arthritis, which is in the top-five worldwide with annual sales of nearly $8 billion.

Top 5 Biotech Stocks To Invest In Right Now: ArQule Inc.(ARQL)

Advisors' Opinion:
  • [By Maxx Chatsko]

    Shares of development-stage biopharma ArQule (NASDAQ:ARQL) rose nearly 17% today after the company announced two appointments to its management team in two newly created positions. Dr. Marc Schegerin will serve as senior vice president, corporate strategy, communication, and finance. Dr. Shirish Hirani will serve as senior vice president, program management and product planning. 

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ArQule (ARQL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we'll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month's Gain  Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85% Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40% Vivis Inc. (Nasdaq: VVUS) $0.77 150.41% Adomani Inc. (Nasdaq: ADOM) $1.49 137.68% NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88% Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06% Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12% ArQule Inc. (Nasdaq: ARQL) $4.88 90.74% LiqTech International Inc. (NYSE: LIQT) $0.66 85.60% Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month's gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

  • [By Ethan Ryder]

    ArQule, Inc. (NASDAQ:ARQL) insider Value Fund L. P. Biotechnology sold 1,035,939 shares of the business’s stock in a transaction dated Wednesday, May 30th. The shares were sold at an average price of $5.00, for a total value of $5,179,695.00. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

  • [By Joseph Griffin]

    ArQule (NASDAQ:ARQL)‘s stock had its “buy” rating restated by equities researchers at Needham & Company LLC in a research report issued to clients and investors on Tuesday, Marketbeat Ratings reports. They currently have a $6.00 price target on the biotechnology company’s stock, up from their prior price target of $5.00. Needham & Company LLC’s price target suggests a potential upside of 134.38% from the company’s previous close.

Monday, February 18, 2019

Best Dividend Stocks To Own For 2019

tags:CEL,TEF,Switzerland,CR,SSBI,TAL,

Private Vista LLC acquired a new stake in shares of Vanguard High Dividend Yield ETF (NYSEARCA:VYM) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 2,500 shares of the company’s stock, valued at approximately $206,000.

Several other hedge funds have also modified their holdings of VYM. Summit Trail Advisors LLC grew its position in shares of Vanguard High Dividend Yield ETF by 5,920.2% during the 1st quarter. Summit Trail Advisors LLC now owns 602,985 shares of the company’s stock valued at $603,000 after acquiring an additional 592,969 shares during the period. LPL Financial LLC grew its position in shares of Vanguard High Dividend Yield ETF by 17.9% during the 4th quarter. LPL Financial LLC now owns 1,998,172 shares of the company’s stock valued at $171,103,000 after acquiring an additional 303,200 shares during the period. Jane Street Group LLC bought a new position in Vanguard High Dividend Yield ETF in the 4th quarter worth $23,659,000. Sawtooth Solutions LLC bought a new position in Vanguard High Dividend Yield ETF in the 4th quarter worth $14,857,000. Finally, M&T Bank Corp boosted its holdings in Vanguard High Dividend Yield ETF by 43.4% in the 1st quarter. M&T Bank Corp now owns 478,073 shares of the company’s stock worth $39,437,000 after buying an additional 144,645 shares during the period.

Best Dividend Stocks To Own For 2019: Cellcom Israel Ltd.(CEL)

Advisors' Opinion:
  • [By Ethan Ryder]

    Hellenic Telecom Organization (NYSE: CEL) and Cellcom Israel (NYSE:CEL) are both utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends and analyst recommendations.

  • [By Lisa Levin]

    Thursday afternoon, the health care shares rose 1.79 percent. Meanwhile, top gainers in the sector included Partner Communications Company Ltd. (NASDAQ: PTNR), up 8 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 7 percent.

  • [By Lisa Levin]

    Thursday afternoon, the telecommunication services shares surged 0.58 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 5 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 2.5 percent.

Best Dividend Stocks To Own For 2019: Telefonica SA(TEF)

Advisors' Opinion:
  • [By Joseph Griffin]

    Shares of Telefonica SA (BME:TEF) have earned a consensus rating of “Hold” from the sixteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is €8.98 ($10.44).

  • [By Max Byerly]

    BME:TEF traded up €0.15 ($0.19) during midday trading on Friday, reaching €8.20 ($10.12). 33,480,000 shares of the stock traded hands, compared to its average volume of 23,390,000. Telef?nica has a 12 month low of €7.45 ($9.20) and a 12 month high of €10.63 ($13.12).

    ILLEGAL ACTIVITY NOTICE: “Telef?nica (TEF) Receives €9.69 Consensus PT from Brokerages” was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3380340/telef%ef%bf%bdnica-tef-receives-9-69-consensus-pt-from-brokerages.html.

    About Telef?nica

  • [By Ethan Ryder]

    Telefonica (BME:TEF) has been assigned a €10.70 ($12.44) target price by Deutsche Bank in a research note issued on Tuesday. The brokerage presently has a “buy” rating on the stock. Deutsche Bank’s target price would suggest a potential upside of 30.49% from the company’s previous close.

  • [By Joseph Griffin]

    Telefonica (NYSE: TEF) and Koninklijke KPN (OTCMKTS:KKPNY) are both large-cap utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, valuation, risk and analyst recommendations.

  • [By Ethan Ryder]

    Telefonica S.A. (NYSE:TEF) has earned an average recommendation of “Hold” from the sixteen brokerages that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company.

  • [By Joseph Griffin]

    Telefonica S.A. (NYSE:TEF) has been given an average rating of “Hold” by the fifteen analysts that are currently covering the stock, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell rating, five have assigned a hold rating and six have issued a buy rating on the company.

Best Dividend Stocks To Own For 2019: Tyco International Ltd.(Switzerland)

Advisors' Opinion:
  • [By ]

    In addition to South Korea’s small ETF, there are a few funds traded in Europe that track Mexican assets. Here are the ones to watch:

    Xtrackers MSCI Mexico UCITS ETF (Germany)iShares MSCI Mexico Capped UCITS ETF USD (Switzerland)HSBC MSCI Mexico Capped UCITS ETF (U.K.)Kim Kindex MSCI Mexico ETF (South Korea)Stocks

    Some of the larger companies based in Mexico are dual listed in Europe. While trading in these securities is limited, there may be some movement in the European morning hours. Here are a few to watch:

Best Dividend Stocks To Own For 2019: CRB Futures Index(CR)

Advisors' Opinion:
  • [By Shane Hupp]

    BlackRock Inc. grew its stake in Crane Co. (NYSE:CR) by 2.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,303,084 shares of the conglomerate’s stock after acquiring an additional 93,264 shares during the period. BlackRock Inc. owned 7.21% of Crane worth $399,069,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Shares of Crew Energy (TSE:CR) have been given a consensus recommendation of “Buy” by the eleven research firms that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is C$3.37.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Crane (CR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Crew Energy (TSE:CR) insider James A. Taylor acquired 5,000 shares of the stock in a transaction that occurred on Monday, June 18th. The stock was acquired at an average cost of C$2.04 per share, for a total transaction of C$10,200.00.

  • [By Ethan Ryder]

    Crew Energy (TSE:CR) had its price objective lowered by equities research analysts at Canaccord Genuity from C$4.50 to C$4.00 in a report issued on Tuesday. Canaccord Genuity’s price objective indicates a potential upside of 101.01% from the stock’s previous close.

Best Dividend Stocks To Own For 2019: Summit State Bank(SSBI)

Advisors' Opinion:
  • [By Max Byerly]

    ValuEngine upgraded shares of Summit State Bank (NASDAQ:SSBI) from a hold rating to a buy rating in a research note released on Saturday.

    Separately, TheStreet raised Summit State Bank from a c+ rating to a b rating in a report on Wednesday, February 14th.

Best Dividend Stocks To Own For 2019: TAL International Group Inc.(TAL)

Advisors' Opinion:
  • [By Shane Hupp]

    TAL Education Group (NYSE:TAL)’s share price gapped up before the market opened on Friday . The stock had previously closed at $25.12, but opened at $26.04. TAL Education Group shares last traded at $26.98, with a volume of 10211680 shares changing hands.

  • [By Shane Hupp]

    Shares of TAL Education Group (NYSE:TAL) have received a consensus rating of “Hold” from the ten research firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $43.46.

  • [By Max Byerly]

    TAL Education Group (NYSE:TAL) was downgraded by analysts at Citigroup from a “buy” rating to a “neutral” rating in a report issued on Thursday, The Fly reports.

Sunday, February 17, 2019

Zacks: Analysts Set $25.00 Target Price for Insteel Industries Inc (IIIN)

Shares of Insteel Industries Inc (NASDAQ:IIIN) have been assigned a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a strong buy rating. Insteel Industries’ rating score has improved by 66.7% from three months ago as a result of a number of analysts’ upgrades and downgrades.

Brokerages have set a 1-year consensus price objective of $25.00 for the company, according to Zacks. Zacks has also assigned Insteel Industries an industry rank of 104 out of 255 based on the ratings given to related companies.

Get Insteel Industries alerts:

IIIN has been the subject of a number of research analyst reports. BidaskClub raised shares of Insteel Industries from a “strong sell” rating to a “sell” rating in a research report on Tuesday, December 18th. Sidoti raised shares of Insteel Industries from a “neutral” rating to a “buy” rating and set a $25.00 price target for the company in a research report on Thursday, January 24th. Finally, TheStreet lowered shares of Insteel Industries from a “b-” rating to a “c” rating in a research report on Thursday, January 17th.

IIIN traded up $0.04 during trading on Friday, hitting $22.05. The company had a trading volume of 160,416 shares, compared to its average volume of 200,072. The stock has a market capitalization of $423.29 million, a PE ratio of 13.27 and a beta of 1.82. Insteel Industries has a 1-year low of $20.13 and a 1-year high of $43.78.

Insteel Industries (NASDAQ:IIIN) last posted its quarterly earnings results on Thursday, January 17th. The industrial products company reported $0.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.07. Insteel Industries had a net margin of 7.02% and a return on equity of 13.50%. The firm had revenue of $104.11 million for the quarter, compared to analysts’ expectations of $106.79 million. During the same period in the prior year, the company posted $0.42 earnings per share. The firm’s quarterly revenue was up 6.5% on a year-over-year basis.

The business also recently declared a quarterly dividend, which will be paid on Friday, March 29th. Stockholders of record on Friday, March 15th will be given a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.54%. The ex-dividend date is Thursday, March 14th.

In related news, Director Jon M. Ruth purchased 4,000 shares of Insteel Industries stock in a transaction dated Friday, December 7th. The stock was acquired at an average cost of $26.04 per share, with a total value of $104,160.00. Following the completion of the transaction, the director now directly owns 5,349 shares of the company’s stock, valued at $139,287.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.20% of the stock is owned by corporate insiders.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of Montreal Can boosted its position in shares of Insteel Industries by 284.8% in the fourth quarter. Bank of Montreal Can now owns 1,543 shares of the industrial products company’s stock valued at $37,000 after acquiring an additional 1,142 shares during the period. PNC Financial Services Group Inc. grew its position in shares of Insteel Industries by 74.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 2,520 shares of the industrial products company’s stock worth $62,000 after buying an additional 1,077 shares during the period. SG Americas Securities LLC acquired a new position in shares of Insteel Industries during the 4th quarter worth about $102,000. Ibex Investors LLC acquired a new position in shares of Insteel Industries during the 3rd quarter worth about $201,000. Finally, Value Holdings Management CO. LLC acquired a new position in shares of Insteel Industries during the 4th quarter worth about $146,000. 79.45% of the stock is owned by institutional investors and hedge funds.

About Insteel Industries

Insteel Industries, Inc, together with its subsidiaries, manufactures and markets steel wire reinforcing products for concrete construction applications. The company offers pre-stressed concrete strand (PC strand) and welded wire reinforcement (WWR) products. Its PC strand is a seven-wire strand that is used to impart compression forces into precast concrete elements and structures providing reinforcement for bridges, parking decks, buildings, and other concrete structures.

Further Reading: Call Option

Get a free copy of the Zacks research report on Insteel Industries (IIIN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Saturday, February 16, 2019

FibroGen (FGEN) Downgraded by ValuEngine to “Buy”

FibroGen (NASDAQ:FGEN) was downgraded by equities researchers at ValuEngine from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Thursday.

A number of other research analysts have also recently weighed in on FGEN. Zacks Investment Research cut FibroGen from a “buy” rating to a “hold” rating in a report on Tuesday, November 13th. Stifel Nicolaus began coverage on FibroGen in a research note on Monday. They set a “buy” rating and a $71.00 price objective on the stock. BidaskClub upgraded FibroGen from a “hold” rating to a “buy” rating in a research note on Saturday, December 22nd. Mizuho restated a “buy” rating and set a $74.00 price objective on shares of FibroGen in a research note on Monday, December 17th. Finally, Citigroup upgraded FibroGen from a “neutral” rating to a “buy” rating and set a $71.00 price objective on the stock in a research note on Tuesday, December 18th. One analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. FibroGen currently has an average rating of “Buy” and a consensus price target of $70.40.

Get FibroGen alerts:

FibroGen stock traded down $0.60 during midday trading on Thursday, reaching $56.96. The stock had a trading volume of 488,800 shares, compared to its average volume of 627,932. FibroGen has a twelve month low of $37.27 and a twelve month high of $68.55. The stock has a market capitalization of $4.89 billion, a P/E ratio of -32.92 and a beta of 1.77. The company has a current ratio of 6.76, a quick ratio of 6.76 and a debt-to-equity ratio of 0.20.

In other FibroGen news, Director James A. Schoeneck sold 2,000 shares of the business’s stock in a transaction dated Thursday, February 7th. The stock was sold at an average price of $57.17, for a total transaction of $114,340.00. Following the transaction, the director now owns 29,700 shares in the company, valued at $1,697,949. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Thomas B. Neff sold 30,000 shares of the business’s stock in a transaction dated Thursday, December 6th. The stock was sold at an average price of $40.93, for a total value of $1,227,900.00. Following the completion of the transaction, the chief executive officer now owns 2,646,320 shares in the company, valued at approximately $108,313,877.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 249,568 shares of company stock worth $11,808,518. 8.96% of the stock is currently owned by insiders.

Several large investors have recently added to or reduced their stakes in the stock. FMR LLC lifted its stake in shares of FibroGen by 6.9% in the third quarter. FMR LLC now owns 8,981,236 shares of the biopharmaceutical company’s stock worth $545,610,000 after acquiring an additional 576,417 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of FibroGen by 1.8% in the third quarter. Vanguard Group Inc. now owns 6,921,874 shares of the biopharmaceutical company’s stock worth $420,503,000 after acquiring an additional 125,186 shares in the last quarter. Vanguard Group Inc lifted its stake in shares of FibroGen by 1.8% in the third quarter. Vanguard Group Inc now owns 6,921,874 shares of the biopharmaceutical company’s stock worth $420,503,000 after acquiring an additional 125,186 shares in the last quarter. BlackRock Inc. lifted its stake in shares of FibroGen by 1.9% in the third quarter. BlackRock Inc. now owns 6,301,117 shares of the biopharmaceutical company’s stock worth $382,796,000 after acquiring an additional 118,460 shares in the last quarter. Finally, Hillhouse Capital Advisors Ltd. acquired a new position in shares of FibroGen in the fourth quarter worth about $92,712,000. Institutional investors and hedge funds own 65.09% of the company’s stock.

FibroGen Company Profile

FibroGen, Inc, a research-based biopharmaceutical company, discovers, develops, and commercializes therapeutic agents to treat serious unmet medical needs. It is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases (HIF-PHs) that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; Pamrevlumab, a human-monoclonal antibody that inhibits the activity of connective tissue growth factor, which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and Duchenne muscular dystrophy; and FG-5200, a corneal implant medical device for the treatment of corneal blindness resulting from partial thickness corneal damage.

Featured Article: Do stock splits help investors?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Friday, February 15, 2019

Top 10 Safest Stocks To Invest In Right Now

tags:ENPH,SAFT,HEES,HOT,EFA,LBTYA,HPP,STC,BRT,WEA,

Nordea (OTCPK:NRBAY) is, for those unfamiliar, the biggest pan-Nordic banking group, having market shares of 15-30% in each of the four Nordic countries: Denmark, Finland, Norway, and Sweden. According to Global Financial Magazine, Nordea was ranked as the 29th safest bank globally in 2017. The ranking was based on the long-term foreign currency ratings issued by Fitch Ratings, Standard & Poor's and Moody's Investors Service.

Source: Company data

Another indicator of its safe-haven status is the fact that Nordea's junior subordinated bonds, or the so-called CoCos, are trading at just a 3.4% yield. For comparison, JPMorgan's (JPM) CoCos are trading at a 5.5% yield.

Top 10 Safest Stocks To Invest In Right Now: Enphase Energy, Inc.(ENPH)

Advisors' Opinion:
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Enphase Energy (ENPH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    This direct current (DC) optimized inverter system maximizes power generation at the individual PV module level while lowering the cost of energy produced by the solar PV system. SolarEdge's patented inverter is not only best in class, but also contains an energy storage unit and/or charger, which differentiates it from its main competitor, Enphase energy (Nasdaq: ENPH).

  • [By Lisa Levin] Gainers Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million. Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results. Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. 21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33. Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27. Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating. PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat. NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399. Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643. Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16. Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results. GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results. The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results. Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 10 Safest Stocks To Invest In Right Now: Safety Insurance Group Inc.(SAFT)

Advisors' Opinion:
  • [By Jordan Wathen]

    The second quarter is usually one of Safety Insurance Group's (NASDAQ:SAFT) best, as warming weather means lower insurance losses for this Massachusetts-based property and casualty insurance company. But this year, this seasonally strong period was especially good, helping Safety earn $26.8 million, a 27% improvement over the year-ago period.

  • [By Jordan Wathen]

    Safety Insurance Group (NASDAQ:SAFT) reported that winter weather activity and an accounting change were drags on its first-quarter results, though a lower tax rate was a net positive to the Massachusetts-based insurance company. 

  • [By Logan Wallace]

    Amerisafe (NASDAQ: SAFT) and Safety Insurance Group (NASDAQ:SAFT) are both small-cap finance companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, risk and dividends.

  • [By Ethan Ryder]

    BidaskClub cut shares of Safety Insurance Group (NASDAQ:SAFT) from a strong-buy rating to a buy rating in a research report released on Friday.

    Several other research analysts also recently weighed in on the stock. Compass Point raised shares of Safety Insurance Group from a sell rating to a neutral rating and set a $70.00 target price for the company in a research note on Thursday, March 8th. ValuEngine raised shares of Safety Insurance Group from a hold rating to a buy rating in a research note on Saturday, June 2nd.

  • [By Max Byerly]

    Safety Insurance Group, Inc. (NASDAQ:SAFT) Director Frederic H. Lindeberg sold 2,000 shares of the business’s stock in a transaction dated Wednesday, June 6th. The shares were sold at an average price of $88.36, for a total value of $176,720.00. Following the completion of the sale, the director now directly owns 16,000 shares of the company’s stock, valued at $1,413,760. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

  • [By Stephan Byrd]

    Arizona State Retirement System reduced its stake in shares of Safety Insurance Group, Inc. (NASDAQ:SAFT) by 7.3% during the 2nd quarter, HoldingsChannel reports. The firm owned 22,220 shares of the insurance provider’s stock after selling 1,760 shares during the period. Arizona State Retirement System’s holdings in Safety Insurance Group were worth $1,898,000 at the end of the most recent reporting period.

Top 10 Safest Stocks To Invest In Right Now: H&E Equipment Services Inc.(HEES)

Advisors' Opinion:
  • [By Peter Graham]

    A long term performance chart shows shares of United Rentals giving a similar performance but also pulling away from small cap peer H&E Equipment Services, Inc (NASDAQ: HEES):

  • [By Logan Wallace]

    H&E Equipment Services (NASDAQ: HEES) and WillScot (NASDAQ:WSC) are both small-cap industrial products companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

  • [By Joseph Griffin]

    SG Americas Securities LLC trimmed its holdings in shares of H&E Equipment Services, Inc. (NASDAQ:HEES) by 42.9% in the 1st quarter, Holdings Channel reports. The firm owned 4,026 shares of the industrial products company’s stock after selling 3,030 shares during the quarter. SG Americas Securities LLC’s holdings in H&E Equipment Services were worth $155,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    H&E Equipment Services (NASDAQ: HEES) and WillScot (NASDAQ:WSC) are both small-cap industrial products companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, institutional ownership and dividends.

Top 10 Safest Stocks To Invest In Right Now: Starwood Hotels & Resorts Worldwide, Inc.(HOT)

Advisors' Opinion:
  • [By Logan Wallace]

    Holo (CURRENCY:HOT) traded 1.6% lower against the US dollar during the one day period ending at 18:00 PM ET on August 18th. Holo has a market capitalization of $82.13 million and approximately $2.55 million worth of Holo was traded on exchanges in the last 24 hours. One Holo token can currently be bought for $0.0006 or 0.00000010 BTC on cryptocurrency exchanges including Hotbit, Binance, Fatbtc and Radar Relay. Over the last seven days, Holo has traded 5.3% lower against the US dollar.

  • [By Shane Hupp]

    Holo (CURRENCY:HOT) traded 0.8% lower against the US dollar during the 24 hour period ending at 20:00 PM E.T. on September 22nd. Holo has a market cap of $148.52 million and approximately $5.90 million worth of Holo was traded on exchanges in the last 24 hours. One Holo token can currently be purchased for approximately $0.0011 or 0.00000017 BTC on major exchanges including IDEX, LATOKEN, Binance and Hotbit. In the last seven days, Holo has traded up 0.1% against the US dollar.

  • [By Stephan Byrd]

    Hydro Protocol (CURRENCY:HOT) traded 0.2% higher against the U.S. dollar during the one day period ending at 0:00 AM ET on October 5th. Over the last seven days, Hydro Protocol has traded 2.8% lower against the U.S. dollar. Hydro Protocol has a total market cap of $7.33 million and $54,859.00 worth of Hydro Protocol was traded on exchanges in the last 24 hours. One Hydro Protocol token can now be purchased for approximately $0.0104 or 0.00000158 BTC on major exchanges including DDEX, Bancor Network, HADAX and Ethfinex.

Top 10 Safest Stocks To Invest In Right Now: iShares MSCI EAFE (EFA)

Advisors' Opinion:
  • [By Logan Wallace]

    Modera Wealth Management LLC lifted its holdings in shares of iShares MSCI EAFE ETF (NYSEARCA:EFA) by 41.2% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 6,703 shares of the exchange traded fund’s stock after acquiring an additional 1,956 shares during the period. Modera Wealth Management LLC’s holdings in iShares MSCI EAFE ETF were worth $449,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    One Capital Management LLC lowered its position in iShares MSCI EAFE ETF (NYSEARCA:EFA) by 35.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,026 shares of the exchange traded fund’s stock after selling 23,427 shares during the quarter. One Capital Management LLC’s holdings in iShares MSCI EAFE ETF were worth $2,814,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Covington Capital Management cut its position in iShares MSCI EAFE ETF (NYSEARCA:EFA) by 9.5% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 204,695 shares of the exchange traded fund’s stock after selling 21,585 shares during the quarter. iShares MSCI EAFE ETF comprises 0.9% of Covington Capital Management’s portfolio, making the stock its 29th biggest holding. Covington Capital Management’s holdings in iShares MSCI EAFE ETF were worth $14,263,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Investors sold shares of iShares MSCI EAFE Index Fund (NYSEARCA:EFA) on strength during trading on Monday. $138.69 million flowed into the stock on the tick-up and $310.48 million flowed out of the stock on the tick-down, for a money net flow of $171.79 million out of the stock. Of all companies tracked, iShares MSCI EAFE Index Fund had the 0th highest net out-flow for the day. iShares MSCI EAFE Index Fund traded up $0.90 for the day and closed at $68.22

Top 10 Safest Stocks To Invest In Right Now: Liberty Global plc(LBTYA)

Advisors' Opinion:
  • [By Stephan Byrd]

    Liberty Global (NASDAQ: LBTYA) is one of 32 public companies in the “Cable & other pay television services” industry, but how does it contrast to its competitors? We will compare Liberty Global to related companies based on the strength of its institutional ownership, analyst recommendations, dividends, valuation, risk, profitability and earnings.

  • [By Stephan Byrd]

    UBS Group upgraded shares of Liberty Global PLC Class A (NASDAQ:LBTYA) from a neutral rating to a buy rating in a research report report published on Friday morning, www.benzinga.com reports. They currently have $33.50 target price on the stock, down from their previous target price of $37.00.

  • [By Joseph Griffin]

    Diamond Hill Capital Management Inc. grew its holdings in shares of Liberty Global PLC Class A (NASDAQ:LBTYA) by 37.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 515,191 shares of the company’s stock after buying an additional 139,156 shares during the quarter. Diamond Hill Capital Management Inc.’s holdings in Liberty Global PLC Class A were worth $14,188,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    These are some of the media stories that may have impacted Accern’s rankings:

    Get Liberty Global alerts: TalkTalk counts the cost of biggest ever customer gains (finance.yahoo.com) $0.12 Earnings Per Share Expected for Liberty Global (LBTYA) This Quarter (americanbankingnews.com) Deal Valuation Disappointing But Liberty Global’s (LBTYA) Valuation Is Too Cheap To Ignore – Citi (streetinsider.com) Virgin Media searches for new leader as chief executive prepares to log off (telegraph.co.uk) Vodafone ‘highly likely’ to receive approval for Liberty Global deal, says Citi (proactiveinvestors.co.uk)

    Shares of Liberty Global traded down $0.17, hitting $28.77, on Thursday, Marketbeat reports. 1,665,800 shares of the company traded hands, compared to its average volume of 2,234,886. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.33 and a current ratio of 0.33. Liberty Global has a 52 week low of $28.00 and a 52 week high of $39.73. The company has a market capitalization of $23.20 billion, a PE ratio of -12.56, a P/E/G ratio of 5.66 and a beta of 1.62.

  • [By Joseph Griffin]

    Epoch Investment Partners Inc. grew its position in shares of Liberty Global PLC Class A (NASDAQ:LBTYA) by 1.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,946,065 shares of the company’s stock after buying an additional 31,331 shares during the period. Epoch Investment Partners Inc. owned about 0.36% of Liberty Global PLC Class A worth $92,241,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Barclays reiterated their buy rating on shares of Liberty Global (NASDAQ:LBTYA) in a report released on Sunday. They currently have a $39.00 target price on the stock.

Top 10 Safest Stocks To Invest In Right Now: Hudson Pacific Properties, Inc.(HPP)

Advisors' Opinion:
  • [By Motley Fool Transcribers]

    Hudson Pacific Properties Inc  (NYSE:HPP)Q4 2018 Earnings Conference CallFeb. 14, 2019, 2:00 p.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Hudson Pacific Properties Inc (NYSE:HPP) has been given an average recommendation of “Buy” by the thirteen ratings firms that are presently covering the firm, Marketbeat reports. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $37.78.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Hudson Pacific Properties (HPP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Hudson Pacific Properties (NYSE:HPP) EVP Sanford Dale Shimoda sold 2,000 shares of the company’s stock in a transaction dated Friday, June 1st. The stock was sold at an average price of $35.72, for a total transaction of $71,440.00. Following the completion of the transaction, the executive vice president now owns 94,478 shares of the company’s stock, valued at approximately $3,374,754.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

  • [By Stephan Byrd]

    Hudson Pacific Properties (NYSE:HPP) EVP Sanford Dale Shimoda sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, June 6th. The stock was sold at an average price of $35.96, for a total transaction of $179,800.00. Following the completion of the transaction, the executive vice president now owns 89,478 shares of the company’s stock, valued at $3,217,628.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Top 10 Safest Stocks To Invest In Right Now: Stewart Information Services Corporation(STC)

Advisors' Opinion:
  • [By Ethan Ryder]

    Stewart Information Services (NYSE:STC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Stewart Information Services Corporation’s primary business is title insurance. Stewart issues policies through issuing locations on homes and other real property located in all 50 states, the District of Columbia and several foreign countries. Stewart also sells computer-related services and information, as well as mapping products and geographic information systems, to domestic and foreign governments and private entities. “

  • [By Stephan Byrd]

    StarChain (CURRENCY:STC) traded down 2.8% against the dollar during the one day period ending at 21:00 PM Eastern on May 31st. One StarChain token can now be bought for about $0.0729 or 0.00000971 BTC on exchanges. StarChain has a market cap of $0.00 and approximately $2.12 million worth of StarChain was traded on exchanges in the last day. In the last seven days, StarChain has traded down 18.5% against the dollar.

  • [By Ethan Ryder]

    StarChain (CURRENCY:STC) traded 8.7% lower against the US dollar during the 24-hour period ending at 20:00 PM E.T. on May 14th. StarChain has a market cap of $0.00 and approximately $5.27 million worth of StarChain was traded on exchanges in the last 24 hours. One StarChain token can now be purchased for about $0.0925 or 0.00001062 BTC on major cryptocurrency exchanges. During the last seven days, StarChain has traded down 16.3% against the US dollar.

  • [By Joseph Griffin]

    Bailard Inc. reduced its stake in shares of Stewart Information Services Corp (NYSE:STC) by 14.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,100 shares of the insurance provider’s stock after selling 1,400 shares during the period. Bailard Inc.’s holdings in Stewart Information Services were worth $335,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    StarChain (CURRENCY:STC) traded 13% higher against the U.S. dollar during the one day period ending at 22:00 PM E.T. on June 3rd. StarChain has a total market capitalization of $0.00 and approximately $3.20 million worth of StarChain was traded on exchanges in the last day. One StarChain token can currently be purchased for about $0.0814 or 0.00001057 BTC on major cryptocurrency exchanges. In the last seven days, StarChain has traded 1.2% lower against the U.S. dollar.

Top 10 Safest Stocks To Invest In Right Now: BRT Realty Trust(BRT)

Advisors' Opinion:
  • [By Joseph Griffin]

    BRT Apartments Corp (NYSE:BRT) announced a quarterly dividend on Tuesday, June 12th, Zacks reports. Shareholders of record on Monday, June 25th will be given a dividend of 0.20 per share by the financial services provider on Friday, July 6th. This represents a $0.80 dividend on an annualized basis and a yield of 6.14%. The ex-dividend date of this dividend is Friday, June 22nd.

  • [By Logan Wallace]

    BRT Apartments Corp (NYSE:BRT) – Equities researchers at B. Riley reduced their FY2018 EPS estimates for BRT Apartments in a research report issued on Tuesday, August 21st. B. Riley analyst C. Kucera now forecasts that the financial services provider will post earnings of $0.94 per share for the year, down from their prior forecast of $1.13. B. Riley also issued estimates for BRT Apartments’ Q4 2018 earnings at $0.18 EPS, Q1 2019 earnings at $0.21 EPS, Q2 2019 earnings at $0.22 EPS, Q3 2019 earnings at $0.23 EPS, Q4 2019 earnings at $0.25 EPS and FY2019 earnings at $0.91 EPS.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on BRT Apartments (BRT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Safest Stocks To Invest In Right Now: Western Asset Bond Fund(WEA)

Advisors' Opinion:
  • [By Shane Hupp]

    Western Asset Premier Bond Fund (NYSE:WEA) hit a new 52-week high and low during mid-day trading on Thursday following a dividend announcement from the company. The stock traded as low as $12.63 and last traded at $12.63, with a volume of 12970 shares changing hands. The stock had previously closed at $12.63.